References
- ATSDR (Agency for Toxic Substances and Disease Registry). 1995. Toxicological profile for di-ethyl phthalate. U.S. Department of Health and Human Services. http://www.atsdr.cdc.gov/toxprofiles/tp73.pdf.
- ATSDR (Agency for Toxic Substances and Disease Registry). 2002. Toxicological profile for Di (2-ethylhexyl) phthalate. http://www.atsdr.cdc.gov/toxprofiles/tp9-p.pdf.
- Barber, E. D., M. Cifone, J. Rundell, R. Przygoda, B. D. Astill, E. Moran, A. Mulholland, E. Robinson, and B. Schneider. 2000. Results of the L5178Y mouse lymphoma assay and the Balb/3T3 cell in vitro transformation assay for eight phthalate esters. J. Appl. Toxicol 20:69–80.
- Cadogan, D., and C. Howick. 1996. Plasticizers. In Kirk-Othmer encyclopedia of chemical technology, ed. K. J. Howe-Grant, vol. 19, 258–190. New York, NY: John Wiley and Sons Inc.
- CDC (Centers for Disease Control and Prevention). 2009a. Fact sheet - Phthalates. http://www.cdc.gov/biomonitoring/Phthalates_FactSheet.html.
- CDC (Centers for Disease Control and Prevention). 2009b. National report on human exposures to environmental chemicals. Benzyl Butyl Phthalate. http://www.cdc.gov/exposurereport/pdf/fourthreport.pdf.
- Chinadaily, 2011. Recall of GSK‘s Augmentin tablet ordered due to plasticizer contamination. Accessed November 1, 2013. http://www.chinadaily.com.cn/china/2011-07/19/content_12937891.htm.
- Choi, S. M., D. S. Lim, M. K. Kim, S. Yoon, S. Kacew, H. S. Kim, and B. M. Lee. 2018a. Inhibition of di(2-ethylhexyl) phthalate (DEHP)-induced endocrine disruption by co-treatment of vitamins C and E and their mechanism of action. J. Toxicol. Environ. Health A 81:748–60. doi:10.1080/15287394.2018.1473262.
- Choi, S. M., T. H. Roh, D. S. Lim, S. Kacew, H. S. Kim, and B. M. Lee. 2018b. Risk assessment of benzalkonium chloride in cosmetic products. J. Toxicol. Environ. Health B 21:8–23. doi:10.1080/10937404.2017.1408552.
- CPSC (Consumer Product Safety Commission). 2010. Toxicity review of Di(isodecyl) phthalate. http://www.cpsc.gov//PageFiles/126534/toxicityDIDP.pdf.
- CPSC (Consumer Product Safety Commission). 2013. Consumer product safety involvement act. Phthalates. https://www.cpsc.gov/phthalates.
- DMA (Danish Medicines Agency). 2009. Information regarding medicines containing dibutyl phthalate. http://laegemiddelstyrelsen.dk/en/service-menu/news/information-regarding-medicines-containi—phthalate.
- Dorman, D. C., W. Chiu, B. F. Hales, R. Hauser, K. J. Johnson, E. Mantus, S. Martel, K. A. Robinson, A. A. Rooney, R. Rudel, et al. 2018. Systematic reviews and meta-analyses of human and animal evidence of prenatal diethylhexyl phthalate exposure and changes in male anogenital distance. J. Toxicol. Environ. Health B 21:207–26. doi:10.1080/10937404.2018.1505354.
- Duty, S. M., N. P. Singh, M. J. Silva, D. B. Barr, J. W. Brock, L. Ryan, R. F. Herrick, D. C. Christiani, and R. Hauser. 2003. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ. Health Perspect 111:1164–69. doi:10.1289/ehp.5756.
- EC (European Commission). 2004. Joint research centre (JRC). European chemicals bureau. Dibutyl phthalate: summary risk assessment report. http://echa.europa.eu/documents/10162/fcd6797a-395c-4f40-83b5-38653200f6cb.
- EFSA (European Food Safety Authority). 2005a. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to bis(2-ethylhexyl) phthalate for use in food contact materials. http://www.efsa.europa.eu/en/efsajournal/doc/243.pdf.
- EFSA (European Food Safety Authority). 2005b. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to dibutyl phthalate for use in food contact materials. http://www.efsa.europa.eu/en/efsajournal/doc/242.pdf.
- Elsisi, A. E., D. E. Carter, and I. G. Sipes. 1989. Dermal absorption of phthalate diesters in rats. Fundam. Appl. Toxicol 12:70–77.
- EPA (U.S. Environmental Protection Agency). 1996. Method 8061A. Phthalate esters by gas chromatography with electron capture detection (GC/ECD). http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/8061a.pdf.
- EPA (U.S. Environmental Protection Agency). 1997. EPA office of compliance sector notebook project: Profile of the pharmaceutical manufacturing industry. http://www.epa.gov/compliance/resources/publications/assistance/sectors/notebooks/pharma.pdf.
- EPA (U.S. Environmental Protection Agency). 2012a. Phthalate Action Plan– Revised version. http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/phthalates_actionplan_revised_2012-03-14.pdf.
- EPA (U.S. Environmental Protection Agency). 2012b. Results from inert ingredient test orders issued under EPA’s endocrine disruptor screening program: New data compensation claims; Potential disapproval of inert uses pending public comment. http://www.gpo.gov/fdsys/pkg/FR-2012-03-14/pdf/2012-6164.pdf.
- EU (European Union). 2005. Directive 2005/84/EC of the European parliament and of the council. Council directive 76/769/EEC. Phthlates in toys and childcare articles. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:344:0040:0043:EN:PDF.
- FDA (U.S. Food and Drug Administration). 1999. Guidance for industry. Container closure systems for packaging human drugs and biologics. http://www.fda.gov/downloads/Drugs/Guidances/ucm070551.pdf.
- FDA (U.S. Food and Drug Administration). 2012a. FDA warns against phthalate use in medicine. http://www.pharmafile.com/news/171935/fda-warns-against-phthalate-use-medicines.
- FDA (U.S. Food and Drug Administration). 2012b. Guidance for industry limiting the use of certain phthalates as excipients in CDER-regulated products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM294086.pdf.
- Foster, P. M., R. C. Cattley, and E. Mylchreest. 2000. Effects of di-n-butyl phthalate (DBP) on male reproductive development in the rat: Implications for human risk assessment. Food Chem. Toxicol 38:97–99. doi:10.1016/S0278-6915(99)00128-3.
- Hauser, R., S. Duty, L. Godfrey-Bailey, and A. M. Calafat. 2004. Medications as a source of human exposure to phthalates. Environ. Health Perspect 112:751–53. doi:10.1289/ehp.6804.
- He, F., Y. Tian, Z. Xu, L. Luo, J. Yang, H. Wang, Y. Sun, Q. Du, and Y. Shen. 2018. Development of an immunochromatographic assay as a screen for detection of total phthalate acid esters in cooking oil. J. Toxicol. Environ. Health A 81:80–88. doi:10.1080/15287394.2017.1414023.
- Hernández-Díaz, S., A. A. Mitchell, K. E. Kelley, A. M. Calafat, and R. Hauser. 2009. Medications as a potential source of exposure to phthalates in the U.S. population. Environ. Health Perspect 117:185–89. doi:10.1289/ehp.11766.
- Heudorf, U., V. Mersch-Sundermann, and J. Angerer. 2007. Phthalates: Toxicology and exposure. Int. J. Hyg. Environ. Health 210:623–34. doi:10.1016/j.ijheh.2007.07.011.
- Howdeshell, K., C. Rider, V. Wilson, and L. J. Gray. 2008. Mechanisms of action of phthalate esters, individually and in combination, to induce abnormal reproductive development in male laboratory rats. Environ. Res 108:168–79.
- IARC (International Agency for Research on Cancer). 2000. IARC monographs on the evaluation of carcinogenic risks to humans: Di-(2-ethylhexyl) phthalate. Volume 77. http://monographs.iarc.fr/ENG/Monographs/vol77/volume77.pdf.
- IARC (International Agency for Research on Cancer). 2013. Monographs on the evaluation of carcinogenic risks to humans. http://monographs.iarc.fr/ENG/Classification/index.php.
- IPCS (International Programme on Chemical Safety). 2003. Diethyl phthalate. Concise international chemical assessment document 52. LC/NLM Classification: QV 612. Geneva, Switzerland: World Health Organization. http://www.inchem.org/documents/cicads/cicads/cicad52.htm.
- Jones, H. B., D. A. Garside, R. Liu, and J. C. Roberts. 1993. The influence of phthalate esters on Leydig cell structure and function in vitro and in vivo. Exp. Mol. Pathol 58:179–93. doi:10.1006/exmp.1993.1016.
- Kelley, K. E., S. Hernández-Díaz, E. L. Chaplin, R. Hauser, and A. Mitchell. 2012. Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ. Health Perspect 120:379–84. doi:10.1289/ehp.1103998.
- Kim, D. H., S. M. Choi, D. S. Lim, T. Roh, S. J. Kwack, S. Yoon, M. K. Kim, K. S. Yoon, H. S. Kim, D. W. Kim, et al. 2018. Risk assessment of endocrine disrupting phthalates and hormonal alterations in children and adolescents. J. Toxicol Environ Health A 81:1150–64. doi:10.1080/15287394.2018.1543231.
- Koo, H. J., and B. M. Lee. 2004. Estimated exposure to phthalates in cosmetics and risk assessment. J. Toxicol. Environ. Health A 67:1901–14. doi:10.1080/15287390490513300.
- KOSHA (Korea occupational safety and health agency). 2006. Pharmaceutical manufacturing (Korean). http://kras.kosha.or.kr/notice/noticeCasebookResult.do?cas_id=72.
- Kwack, S. J., K. B. Kim, H. S. Kim, and B. M. Lee. 2009. Comparative toxicological evaluation of phthalate diesters and metabolites in Sprague-Dawley male rats for risk assessment. J. Toxicol. Environ. Health A 72:1446–54. doi:10.1080/15287390903212923.
- Lee, B. M., and S. Kacew. 2018. Advances in toxicological research and risk assessment. J. Toxicol. Environ. Health A 81:240. doi:10.1080/15287394.2018.1439689.
- Lee, B. M., and H. J. Koo. 2007. Hershberger assay for antiandrogenic effects of phthalates. J. Toxicol. Environ. Health A 70:1365–70. doi:10.1080/15287390701432285.
- Lim, D. S., S. M. Choi, K. B. Kim, K. Yoon, S. Kacew, H. S. Kim, and B. M. Lee. 2018a. Determination of fragrance allergens and their dermal sensitization quantitative risk assessment (QRA) in 107 spray perfumes. J. Toxicol. Environ. Health A 81:1173–85. doi:10.1080/15287394.2018.1543232.
- Lim, D. S., T. H. Roh, M. K. Kim, Y. C. Kwon, S. M. Choi, S. J. Kwack, K. B. Kim, S. Yoon, H. S. Kim, and B. M. Lee. 2018b. Non-cancer, cancer, and dermal sensitization risk assessment of heavy metals in cosmetics. J. Toxicol. Environ. Health A 81:432–52. doi:10.1080/15287394.2018.1451191.
- MFDS (Ministry of Food and Drug Safety). 2000. Basic research on relationship between endocrine disrupting chemicals (EDCs) and human health effect (Korean). 2:173–94.
- MFDS (Ministry of Food and Drug Safety). 2009. Changes in permitted fact on imported or manufactured drug. Pharmaceutical management division 11865 (Korean). http://www.mfds.go.kr/index.do?x=1024&searchkey=title:contents&mid=70&searchword=%C0%C7%BE%E0%C7%B0%20%C1%A6%C1%B6(%BC%F6%C0%D4)%C7%B0%B8%F1%20%C7%E3%B0%A1%BB%E7%C7%D7%20%BA%AF%B0%E6%C1%F6%BD%C3&cd=&y=−357&pageNo=3&seq=7344&cmd=v.
- MHRA (Medicines and Healthcare Products Regulatory Agency). 2007. Safety information –Technical information. Phthalates/DEHP in PVC medical devices. http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Technicalinformation/PhthalatesinPVCmedicaldevices/.
- NTP (National Toxicology Program). 1989. Fifth Annual Report on Carcinogens: Summary 1989. NC: National Institute of Environmental Health Sciences, Research Triangle Park. http://legacy.library.ucsf.edu/tid/sar93a99/pdf;jsessionid=A60985B2C99DC3596B1950F30A2F9F36.tobacco03.
- OSHA (Occupational Safety and Health Administration). 1995. Occupational safety and health guideline for diethyl phthalate. http://www.cdc.gov/niosh/docs/81-123/pdfs/0213.pdf.
- Rao, P. R., and P. V. Diwan. 1997. Permeability studies of cellulose acetate free films for transdermal use: Influence of plasticizers. Pharm. Acta. Helv 72:47–51.
- Scott, R. C., P. H. Dugard, J. D. Ramsey, and C. Rhodes. 1987. In vitro absorption of some o-phthalatediesters through human and rat skin. Environ. Health Perspect 74:223–27. doi:10.1289/ehp.8774223.
- Seckin, E., H. Fromme, and W. Völkel. 2009. Determination of total and free mono-n-butyl phthalate in human urine samples after medication of a di-n-butyl phthalate containing capsule. Toxicol. Lett 188:33–37. doi:10.1016/j.toxlet.2009.03.002.
- Shin, I. S., M. Y. Lee, E. S. Cho, E. Y. Choi, H. Y. Son, and K. Y. Lee. 2014. Effects of maternal exposure to di(2-ethylhexyl)phthalate (DEHP) during pregnancy on susceptibility to neonatal asthma. Toxicol. Appl. Pharmacol 274:402–07. doi:10.1016/j.taap.2013.12.009.
- Smith, C. C. 1953. Toxicity of butyl stearate, dibutyl sebacatd, dibutyl phthalate, and methoxyethyl oleate. Arch. Ind. Hyg. Occup. Med 7:310–18.
- Uhde, E., M. Bednarek, F. Fuhrmann, and T. Salthammer. 2001. Phthalic esters in the indoor environment-test chamber studies on PVC-coated wallcoverings. Indoor Air 11:150–55.
- Wolfe, G. W., and K. A. Layton. 2003. Multigeneration reproduction toxicity study in rats (unaudited draft): Diethylhexylphthalate: Multigenerational reproductive assessment when administered to Sprague-Dawley rats in the diet. TherImmune Research Corporation (Gaithersburg, Maryland), TRC Study n° 7244-200.